Business ❯Pharmaceuticals ❯Drug Development

Weight Loss Drugs

Pharmaceuticals Stock Market Type 2 Diabetes Clinical Trials Medications Weight Loss Drugs Telehealth Leadership Changes Stock Performance Leadership

19 ARTICLES

last mo.

Novo Nordisk Ends Partnership With Hims & Hers Over Compounded Wegovy Sales

Novo Nordisk cited patient safety concerns in compounded semaglutide sourced from unapproved Chinese suppliers after the FDA declared the GLP-1 shortage over.

31 ARTICLES

2mo ago

AbbVie Enters Obesity Drug Market with $2.2 Billion Licensing Deal

Weight Loss Drugs

Novo Nordisk Ends Partnership With Hims & Hers Over Compounded Wegovy Sales

Novo Nordisk CEO Steps Down Following Share Price Collapse

Novo Nordisk Seeks FDA Approval as Eli Lilly's Weight-Loss Pill Advances

Roche and Zealand Partner in $5.3 Billion Deal for Obesity Drug Development

AbbVie Enters Obesity Drug Market with $2.2 Billion Licensing Deal